perioperative management of glp-1 agonists receptor like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the setting. These Glucagon-Like Peptide-1 Receptor Agonists in
Description
Effect of semaglutide 2.4 mg once weekly on 10-year type 2 diabetes risk in adults with overweight or obesity
In addition, few studies currently support the use of GLP-1RAs in patients with HFrEF
What happens when people stop taking GLP-1 drugs
In our discovery studies GLP-1 enhanced satiety during a meal but lacked the insulinotropic effect in the natural setting of people consuming mixed meals (Fig
however, while it effectively lowers glycated hemoglobin (HbA1c), it has minimal effects on weight loss and limited durability in glycemic control
